| A | B | C | |
|---|---|---|---|
| 1 | Main | ||
| 2 | Brand | VLA15 | |
| 3 | Indication | Lyme Disease vaccine | |
| 4 | Economics | Valneva partnership | |
| 5 | Clinical Trials | ||
| 6 | Phase II pediatric | ||
| 7 | |||
| 8 | Phase III - initiating Q322 |
| A | B | C | |
|---|---|---|---|
| 1 | Main | ||
| 2 | Brand | VLA15 | |
| 3 | Indication | Lyme Disease vaccine | |
| 4 | Economics | Valneva partnership | |
| 5 | Clinical Trials | ||
| 6 | Phase II pediatric | ||
| 7 | |||
| 8 | Phase III - initiating Q322 |
Martin Shkreli